Dublin, March 12, 2018 -- The "United States and Japan Proton Therapy Market Analysis 2012 to 2017 and Forecast 2018 to 2025" report has been added to ResearchAndMarkets.com's offering.
United States and Japan Proton Therapy Market Analysis 2012 to 2017 and Forecast 2018 to 2025 presents an in-depth assessment of the proton therapy market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends.
The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for proton therapy in the United States and Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025.
A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies. The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers.
n addition, the report also provides essential insights on number of patients treated at US and Japan proton therapy centers. The report also includes assessment of US and Japan reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the US and Japan proton therapy market.
The report concludes with the profiles of major players in the US and Japan proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies, recent development of the proton therapy market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Hitachi, Optivus, Ion Beam Applications (IBA), Varian Medical Systems, Mevion Medical Systems, Mitsubishi Electric, Sumitomo Heavy Industries Ltd.
Key Findings:
- United States proton therapy market will exhibit growth by a CAGR of over 15% up to 2025
- The potential United States and Japan proton therapy market is set to cross USD 10 Billion by 2025
- In 2017, IBA accounted highest number of proton therapy centers in United States
- Hitachi has the second highest number of treatment rooms in United States and Japan
- Hitachi and Mitsubishi Electric Merged Proton Therapy System Business
Key Topics Covered:
1. Executive Summary
2. What is Proton Therapy?
3. Proton Therapy Current Applications
4. Proton Therapy Comparative Analysis
4.1 Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
4.2 Proton Therapy Competitive Analysis: By Company
5. Market Size & Analysis: United States & Japan Proton Therapy (2012 - 2025)
5.1 United States
5.1.1 Proton Therapy Patients Treated Statistics (Volume)
5.1.2 Proton Therapy Market Analysis (Value)
5.2 Japan
5.2.1 Proton Therapy Patients Treated Statistics (Volume)
5.2.2 Proton Therapy Market Analysis (Value)
6. Market Opportunity Assessment: United States & Japan Proton Therapy (2012 - 2025)
6.1 United States
6.1.1 Potential Proton Therapy Patient Base (Volume)
6.1.2 Potential Proton Therapy Market Demand Analysis (Value)
6.2 Japan
6.2.1 Potential Proton Therapy Patient Base (Volume)
6.2.2 Potential Proton Therapy Market Demand Analysis (Value)
7. Key Market Drivers and Inhibitors of the United States Proton Therapy Market
7.1 Market Drivers
7.2 Market Inhibitors
8. United States & Japan Number of Treatment Rooms and Forecast (2012 - 2025)
8.1 United States
8.2 Japan
9. United States & Japan Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
9.1 United States
9.1.1 Proton Therapy Center (Installed Base) Market Share
9.1.2 Treatment Room Market Share
9.2 Japan
9.2.1 Proton Therapy Center (Installed Base) Market Share
9.2.2 Treatment Room Market Share
10. United States & Japan Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
10.1 United States
10.1.1 Current Proton Therapy Centers
10.1.2 Demand for Proton Therapy Centers
10.2 Japan
10.2.1 Current Proton Therapy Centers
10.2.2 Demand for Proton Therapy Centers
11. United States & Japan Number of Patients Treated at Proton Therapy Centers
11.1 United States
11.2 Japan
12. United States Proton Therapy Reimbursement Scenario
12.1 United States
12.2 Japan
13. Proton Therapy Center Component Analysis
13.1 Proton Accelerator
13.2 Beam Transport System
13.3 Beam Delivery System
13.4 Nozzle
13.5 Treatment Planning System
13.6 Image Viewers
13.7 Patient Positioning System (PPS)
13.8 Human Resource
14. Proton Therapy Clinical Trail Insight by Phase, Institute & Country
14.1 Year 2017
14.2 Year 2016
15. Major Deals in Proton Therapy Market
15.1 Collaboration Deals
15.2 Licensing Agreement
15.3 Exclusive Agreement
15.4 Partnership Deals
15.5 Venture Capital Investment
15.6 Development Agreement
16. Key Companies Analysis
- Hitachi
- Ion Beam Applications (IBA)
- Mevion Medical Systems
- Mitsubishi Electric
- Optivus
- Sumitomo Heavy Industries Ltd
- Varian Medical Systems
For more information about this report visit https://www.researchandmarkets.com/research/42x3sk/united_states_and?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Nuclear Medicine and Radiopharmacology


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Anta Sports Expands Global Footprint With Strategic Puma Stake
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



